Delivery Order SPE2DB20D3505-SPE2DB25FV1F1
- Not listed
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.44 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract, awarded on July 25, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 15 mg nasal sprays, a medication used for acute seizure management. This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,373.64 and an ultimate completion date of August 11, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, valued at $2,257.08 under firm fixed pricing. This delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 10 mg nasal spray, a seizure rescue medication. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.67 and is scheduled for completion by August 4, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV1F1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. No set-aside designation was used for this award, indicating open and competitive procurement. Performance of this delivery order occurs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is an emergency treatment for acute repetitive seizure clusters in patients with epilepsy, reflecting the Defense Logistics Agency's ongoing need to supply specialized pharmaceuticals to support military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor through its comprehensive portfolio of medical product deliveries, including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling DLA's medical supply chain requirements through its prime vendor global program, which supplies healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/4/25 |